A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors

NCT07354711 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Stomach Cancer

Interventions

DRUG: 3H-10000

Sponsor

3H Pharmaceuticals Co., Ltd.